共 50 条
- [3] Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells JOURNAL OF NEUROINFLAMMATION, 2015, 12
- [4] Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells Journal of Neuroinflammation, 12
- [9] Expression of L-selectin (CD62L), CD44, and CD25 on activated bovine T cells FASEB JOURNAL, 2003, 17 (07): : C287 - C287